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Many Iowans have heard about the “medical 
marijuana” programs in states like Colora-
do.  What many don’t realize is the 
“medical” marijuana is often the same crude 
street drug sold under names like AK 47, 
Black Witches Brew or Green Crank in a 
“medical” marijuana dispensary.  In many 
ways it would be like putting the label 
“medical” on vodka and calling it “medical 
vodka”.  
The American Medical Association recently 
reaffirmed its opposition to smoking mariju-
ana.  Many medical groups cite the lifelong 
harmful effects smoking marijuana can have, 
especially on youth.    
Advocates of the medical use of the drug 
often cite compassion as their argument, and 
indeed no one wishes for another to suffer 
needlessly.  To help people with severe med-
ical conditions who cannot find relief with 
other medications, the FDA has already 
approved several medicines derived from 
the cannabis plant.  Several more are in the 
research and development phase.   
In lieu of medical marijuana programs that 
are often a guise for people profiting from 
addictions, we should focus resources on 
developing safe, effective medications that 
meet FDA standards.  Several of these are 
discussed in this issue of the Connection.  
Sincerely,  
 
 
Steven F. Lukan 
D IRECTOR ’S NOTES 
CBD VS . THC 
Marijuana has many chemicals, the most well 
known of which is THC, or delta-9-
tetrahydrocannabinol.  
 
Research and science have proven there is 
medical value in a different derivative of the 
marijuana plant called cannabidiol or CBD. 
CBD may have analgesic, anti-inflammatory, 
and anti-anxiety properties. However, unlike 
THC, CBD does not produce the psychoactive 
effects of feeling high or stoned.  
 
Studies indicate that CBD could be effective in 
easing symptoms of a wide range of difficult-to
-control conditions such as PTSD, epilepsy, 
and other.  
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Epidiolex is an oral liquid formulation with a highly purified 
extract of plant-derived cannabidiol (CBD) as its active in-
gredient. GW Pharmaceuticals announced that it has been 
granted seven expanded access investigational new drug 
programs by the US Food and Drug Administration (FDA) 
for the treatment of 125 children suffering from intractable 
epilepsy syndrome in 2014. GW has also made arrange-
ments to enable independent US pediatric epilepsy special-
ists to treat high need cases immediately. Epidiolex is THC-
free, which ensures the children will not get “high” from the 
medicine.  
 
Sativex is a cannabinoid mouth spray medicine approved in 
20 countries, and in the process of being studied in the US. 
A decision from the FDA is expected in the next few 
months. The active components are delta-9-
tetrahydrocannabinol (THC) and cannabidiol (CBD). Sa-
tivex is used for the symptomatic relief of neuropathic pain 
in multiple sclerosis in adults.  
 
Source: GW Pharmaceuticals 
SATIVEX & EPIDIOLEX 
MARINOL & CESAMET 
Marinol (dronabinol) is a pill that contains lab-made THC. 
It is widely available at pharmacies to treat nausea/vomiting 
from cancer chemotherapy. Marinol has also been approved 
by the FDA for treatment of anorexia in AIDS patients.  
 
Cesamet (nabilone) is a synthetic cannabinoid that mimics 
the THC found in cannabis. Cesamet was approved by the 
FDA because it was found to help certain patients. It is a 
medicine used for nausea and vomiting caused by cancer 
chemotherapy. It is used when other drugs have not been 
able to control these symptoms. Although it is not official 
indicated for chronic pain management, it is often used for 
that purpose. It is also approved for the use in treatment of 
anorexia and weight loss in AIDS patients.  
